← Back to BOLD

Boundless Bio, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 07/08/2026Mar 2026Filed 08/05/2026Sep 2025Filed 05/11/2025Jun 2025Filed 07/08/2026Mar 2025Filed 08/05/2026Sep 2024Filed 05/11/2025Jun 2024Filed 05/08/2025Mar 2024Filed 09/05/2025
−$24−$14−$14−$16−$16−$17−$17−$15
−$1.06−$0.60−$0.62−$0.70−$0.71−$0.74−$0.77−$12.27
222222222222221.3

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.